— Know what they know.
Not Investment Advice

NUVL NASDAQ

Nuvalent, Inc.
1W: -3.0% 1M: -7.0% 3M: +0.7% YTD: +0.4% 1Y: +33.4% 3Y: +153.3%
$102.12
+0.88 (+0.87%)
 
Weekly Expected Move ±4.5%
$93 $98 $102 $107 $112
NASDAQ · Healthcare · Biotechnology · Alpha Radar Sell · Power 34 · $7.5B mcap · 49M float · 1.15% daily turnover · Short 56% of daily vol

Income Trends

Revenue
$0 +0.0% ▲
Gross Profit
$0 +0.0% ▲
Operating Income
-$414M -47.8% ▼
Net Income
-$425M -63.1% ▼
EPS (Diluted)
$-5.85 -48.9% ▼
EBITDA
-$10M +0.0% ▲

Profit Margins

Year-over-Year Growth

View Full Income Statement
Line ItemFY2021FY2022FY2023FY2024FY2025
Revenue$0$0$0$0$0
YoY Growth+0.0%+0.0%+0.0%+0.0%+0.0%
Cost of Revenue$0$0$0$0$0
Gross Profit$0$0$0$0$0
Gross Margin
R&D Expenses$36M$64M$113M$218M$307M
SG&A Expenses$10M$22M$36M$63M$107M
Operating Expenses$46M$86M$149M$280M$414M
Operating Income-$46M-$86M-$149M-$280M-$414M
Operating Margin
Interest Expense$0$0$23M$0$0
Income Before Tax-$46M-$82M-$126M-$260M-$425M
Tax Expense$0$0$0$764K$585K
Net Income-$46M-$82M-$126M-$261M-$425M
Net Margin
EPS (Diluted)$-2.13$-1.65$-2.17$-3.93$-5.85
EBITDA-$46M-$86M-$126M$0-$10M
Shares Outstanding22M50M58M66M73M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms